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This brief report describes, in very general terms, Montgomery County residents who presented 
to Emergency Departments (EDs) at hospitals in Montgomery County for treatment of an 
accidental drug overdose (OD) from 2007-2010. Its purpose is to broaden the perspective on the 
unintentional drug overdose problem as manifested in Montgomery County, Ohio. To date, the 
issue has been framed largely by mortality data from the Montgomery County Coroner’s Office 
and the Ohio Department of Health. While highly informative and extremely useful, these data 
only partially reflect the nature and extent of the problem as they are based solely on people who 
have died from an accidental drug overdose. It is our hope that bringing local ED OD data to 
light will help inform the discussion and lead to an appropriate response to a public health 




Tabulations in this report are based on data provided in a de-identified form by the Greater 
Dayton Area Hospital Association. The data were used to gain a better understanding accidental 
OD phenomenon in Montgomery County as well as to develop a very rough profile of residents 
who presented to EDs in Montgomery County for treatment of accidental drug overdoses. 
 
The variables considered were age, gender, race/ethnicity, residency, and ICD-9 codes for 
selected drugs. Residency was determined by the zip code information collected by the hospitals. 
ICD-9 codes identified accidental (as opposed to intentional) overdoses associated with specific 
drugs or drug types. International Classification of Diseases – Ninth Revision (ICD-9) codes are 
used by hospitals to specify diagnoses on billable reimbursement claims.  ICD-9 codes were used 
to enumerate ED ODs associated with the following 7 drugs/drug types: amphetamines, 
benzodiazepines, cocaine, hallucinogens, heroin, methadone, and prescription (Rx) opioids other 
than methadone.  
 




Between January 1, 2007 and December 31, 2010, EDs in Montgomery County treated 1,937 
Montgomery County residents who received ICD-9 codes indicating accidental drug poisonings. 
Of these, 1622 (83.7%) visits (373 in 2007; 447 in 2008; 415 in 2009; 387 in 2010) involved one 
or more of the aforementioned 7 drugs (see Graphs on pages 2-3). Of the 315 cases not included 
in this report, 265 (84.1%) involved either antidepressants or anti-psychotics. The remainder 
involved barbiturates, alcohol, or other drugs whose identity could not be determined with 



































































































2007 2008 2009 2010
Cocaine 86 76 57 60
Heroin 71 99 90 67
Methadone 31 27 29 30
RX Opioids 108 140 139 130
Benzodiazepines 136 173 178 170







































































The data upon which this report is based are subject to a number of limitations. First, the data are 
from hospital billing departments, not medical record reviews. Sometimes there are differences 
between patient medical records and how diagnoses are coded and subsequently billed. Second, 
not all accidental drug overdoses are diagnosed as such. Thus, the data in this report likely 
somewhat underestimate the extent of the problem. Third, for a variety of reasons, the identity of 
the drug(s) on which a person has overdosed is not always verified by toxicology tests at a 
hospital during an ED visit. Simply, sometimes there is no quick test for the drug which has 
caused the problem.  For example, as of this writing, methcathinone, MDPV and mephedrone, 
possible ingredients in some “bath salts,” are not detectable with an instant urine or saliva test. 
Further, there is, as of this writing, some variation in the ICD-9 coding of “bath salt” overdoses. 
Sometimes they are coded under Hallucinogens, sometimes under Stimulants, and sometimes 
under Unspecified agents. Consequently, there is some reason to believe that not every 
accidental drug overdose case is coded appropriately with respect to the poisoning agent. Fourth, 
a person who has overdosed on two (or more) drugs that fall under the same ICD-9 code, e.g., 
hydrocodone and oxycodone (ICD-9 code E850.2), are coded only once. Thus, the number of 
mentions for a specific drug (or drug type or drug class) cited in this report are likely lower than 
their actual occurrence since a single code may not reflect the complete poisoning picture.  Fifth, 
zip codes are imperfect indicators of the extent and location(s) of the problem within the county. 
This has a number of implications. For example, only people who reported an address with a 
Montgomery County zip code are included in the data set. Thus, non-residents who overdosed in 
Montgomery County and visited a hospital in Montgomery County are not included in the data. 
Similarly, Montgomery Country residents who overdosed and presented at a hospital outside of 
Montgomery County are not included in the data either. In addition, although the vast majority of 
zip codes in this report are contained within the boundaries of Montgomery County, several 
bleed into contiguous counties. Sixth, the data presented represent visits/cases, not separate 
individuals. Since the data were de-identified, it is not possible to ascertain the number of people 
who contributed more than one case to the data base. Seventh, although the data show how many 
cases were treated at EDs in Montgomery County from 2007-2010, they do not reflect the extent 
of the overdose problem, not only for some of the reasons noted above, but also because there is 
evidence to indicate the vast majority of persons who die from accidental drug overdoses die 
before reaching an ED. For example, in 2010, only 20 of the 127 (15.7%) people who died in 
Montgomery County from an unintentional drug overdose reached a hospital ED. Thus, when 
factoring in data from the Montgomery County Coroner’s Office, there is good reason to think 
there are, on average, 500 plus cases of accidental drug overdose the in the county each year 
involving the selected drugs highlighted in this report. In addition, for a variety of reasons, an 
unknown number of drug overdoses never come to the attention of medical centers or legal 
authorities. Some ODs are treated by bystanders, friends and family at the scene of the event for 
fear of legal repercussions.  
 
Even with these limitations, the data provide important perspective on the accidental drug 
overdose problem in Montgomery County. Perhaps the most interesting and potentially useful 
finding emanates from the zip code data. Although OD ED cases occur across the county 
(indeed, the Miami Valley, Ohio and the US) and in all zip codes, more than one-half (52.5%) of 




pages 8-10). There are 39 zip codes in Montgomery County. It is important to note that 
population density varies across zip codes as do a host of economic and demographic factors.  
Nevertheless, while these findings may surprise some observers and not others, they can help 
geographically target neighborhood-level interventions to help reduce the accidental OD 
problem. Such interventions could be implemented following well-known health behavior theory 
and public health practices. While interventions targeting users and their families may help 
reduce the problem, they will not solve it as the problem is multi-factorial in nature (Webster et 
al. 2011), and public health-oriented interventions will not impact all factors.  
  
Drug mentions from ED ODs are very consistent with Montgomery County Coroner’s Office 
toxicology reports in that data from both sources show sedatives/tranquilizers and Rx opioids are 
the most frequently mentioned drugs relative to other drugs in accidental OD cases. The most 
frequently mentioned drugs in the Coroner’s Office 2010 autopsy reports were sedatives, 93% of 
which were benzodiazepines, followed Rx opioids (WSU CITAR 2011); the most frequently 
mentioned drugs in ED OD cases, regardless of the sample size (1937 or 1622), were 
benzodiazepines, such as alprazolam, followed by Rx opioids, such as hydrocodone and 
oxycodone. The relatively large number of people suffering an OD caused or complicated by 
benzodiazepines demonstrates not only that they are widely prescribed and misused but that their 
use can result in symptoms which may precipitate an ED visit. Fortunately, most 
benzodiazepines have relatively high margins of safety when not combined with other drugs that 
depress the central nervous system (CNS). When combined with other CNS depressants, such as 
an opioid or alcohol, benzodiazepine use can be very problematic, sometimes lethal.  
 
Specific drug mention data for the four year time period covered by this report show a large 
increase in benzodiazepine and Rx opioids (exclusive of methadone) mentions from 2007 to 
2008, then stabilization. Methadone mentions (virtually all of which are related to methadone 
prescribed for pain relief, not methadone used to treat drug addiction) have remained stable over 
the reporting period. Cocaine mentions appear to have decreased somewhat, while heroin 
mentions reveal no pattern.  Notably, any given case can contribute more than one drug to the 
drug mention count. In fact, data show that, at a minimum, given the aforementioned limitation 
in ICD-9 coding, about 14% of the ED OD cases involved people who had more than one opioid 
(heroin, methadone, other Rx opioids) in their system, or an opioid and a benzodiazepine, upon 
arrival at the hospital. Generally, accidental ODs involving multiple CNS depressants have the 
highest likelihood of very bad outcomes.  
 
Recently published data from the CDC show the most widely prescribed drugs in the United 
States for people aged 20-59 were anti-depressants followed very closely by analgesics. CDC 
data also show that proportionately more women than men are prescribed these drugs, as are 
whites compared to other racial/ethnic groups (Gu et al. 2010). Thus, it is not surprising that 
women and whites made up a larger proportion of the ED OD population in Montgomery County 
than did other groups. Notably, age and race/ethnicity data for Montgomery County ED ODs are 
very much in concert with 2010 US Census data for the county. In terms of gender, census data 
show about 52% of Montgomery County residents are women; racially/ethnically, about 74% of 





Although this report focuses on the general demographics of people who overdosed and the 
specific types of drugs that brought them to an ED, the cost of OD ED visits merits some 
mention. We computed the average billed cost of outpatient treatment (an ED OD visit where the 
patient was not admitted to the hospital as an inpatient, aka treat-and-release) for an opioid 
(including heroin) overdose in 2010. The average cost, based on 54 visits where the primary 
ICD-9 code was an opioid poisoning, was $4588 per case.  This suggests that the cost of treating 
the 227 opioid cases presenting at area hospital EDs in 2010 was, at a minimum, $1,041,476. 
Notably, these costs do not factor in those associated with the services provided by publically-
funded Emergency Medical Services.  Additionally, if opioid OD cases resulting in inpatient 
treatment had been considered, the monetary costs would be substantially more, as the cost for 
these cases is much higher than for treat-and-release cases. Further, the OD treatment cost for 
other drugs, such as benzodiazepines, was not calculated. The critically important point here is 
that, aside from the incalculable human costs associated with drug overdoses, there is a 




This is a brief report with a number of limitations. Still, it provides information that allows 
additional insight into the accidental drug overdose problem in our community.  The nature and 
extent of the phenomenon are clearer. Aside from the 500 plus Montgomery County residents 
who experienced an OD in 2010, their family, friends, and co-workers were also affected by the 
event in some way. So, in a real sense, these unintentional ODs likely touched thousands of 
people. We also now have a better idea of the short-term health care costs associated with a 
segment of the OD problem.  Virtually all of us pay for the problem, and the costs, whether 
human and financial, are not insignificant. We also know that although the problem exists across 
the county, it is more prevalent in some areas than in others. This finding could be useful in the 
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mapping; Kym Sellers, WSU CITAR, editorial support; and the Greater Dayton Area Hospital 
Association and area hospitals for the data. This report was funded, in part, under a contract from Public 
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Overdose Cases Resulting in Death, 2007-2010 
Montgomery County, Ohio 
 
          













Overdose Cases Resulting in ED Visits, 2007-2010 















Overdose Cases, 2007-2010 
(ED ODs and Deaths Combined) 




















































                 
DEMOGRAPHICS 
Characteristic  Data Source             
       Category  Freq  Percent 
2010 
Percent 
Age  Death Certificate  <15 years  0  0%  0%
      15‐24 years  6  6%  14%
      25‐34 years  17  18%  22%
      35‐44 years  25  26%  28%
      45‐54 years  32  33%  18%
      55‐64 years  10  10%  16%
      65‐74 years  1  1%  2%
      75+ years  0  0%  0%
Gender  Death Certificate  Male  59  61%  57%
      Female  38  39%  43%
Race  Death Certificate  White  85  88%  90%
      Black  12  12%  10%
      Other  0  0%  0%
Hispanic  Death Certificate  Hispanic/Latino  0  0%  0%
Education  Death Certificate  <High School  29  30%  20%
      HS graduate  63  66%  76%
      College graduate  3  3%  2%
      Post‐graduate  1  1%  1%
Marital Status  Death Certificate  Single  37  39%  41%
      Married  31  32%  29%
      Divorced  22  23%  26%
      Separated  4  4%  2%
      Widowed  2  2%  2%
Military  Death Certificate 
Ever in US Armed 
Forces  3  3%  13%
         















Disability/Illness     70  72%  79%






      2011 Cases  97    
2010 Cases: 
127








Any history     83  86%  75%
Alcohol     20  21%  13%
Cocaine     17  18%  12%
Marijuana     2  2%  5%
Heroin     25  26%  26%
Prescription opioids     32  33%  27%
Benzodiazepines     20  21%  15%
Other Prescription 
Medications     7  7%  3%
Over‐the‐Counter 
Medications     0  0%  0%
DEATH INVESTIGATION 
Characteristic  Data Source  Category          
         Freq  Percent 
2010 
Percent 
Location of death  Case Synopsis  Decedent's home  51  53%  68%
      Relative's home  0  0%  2%
      Friend's home  19  20%  14%
      Place of work  1  1%  0%
      School  0  0%  0%





      Drug tx facility  0  0%  0%
      Jail/detention area  0  0%  0%
      Public area  0  0%  2%
      Other  5  5%  4%




Coroner  0  0%  1%
      Hospital physician  21  22%  17%
      Other physician  0  0%  0%
      Mortician  0  0%  0%







Report     11  11%  11%
                 
TOXICOLOGY REPORT                
      2011 Cases  97    
2010 Cases: 
127





Alcohol  23  24%  23%
Illicit Drugs  Marijuana  39  40%  30%
   Cocaine  39  40%  30%
   Methamphetamine  2  2%  1%
   Heroin  32  33%  31%
Prescription Opioids  Any  61  63%  74%
   Oxycodone  16  16%  23%
   Hydrocodone  16  16%  24%
   Methadone  36  37%  32%
   Fentanyl  7  7%  7%
   Tramadol  4  4%  6%
   Hydromorphone  0  0%  1%
   Morphine  8  8%  9%
   Other  4  4%  4%
Anti‐Depressants  Any  29  30%  38%
Sedatives (Including 






























   7  7%  9%
Heroin+ Any 
Prescription Opioid 
AND/OR Any Sedative     22  23%  21%
Heroin WITHOUT 
Alcohol, Prescription 
Opioids, or Sedatives     5  5%  4%
Other Prescription  Any  32  33%  39%




Toxicology Report           36%  33%
 
 














Opioids:        61  63%  74%
Age  Death Certificate  <15 years  0 0%  0%
      15‐24 years  5  8%  13%
      25‐34 years  10  16%  23%
      35‐44 years  15  25%  27%
      45‐54 years  22  36%  19%
      55‐64 years  9  15%  17%
      65‐74 years  0  0%  1%
      75+ years  0  0%  0%
Gender  Death Certificate  Male  29  48%  53%
      Female  32  52%  47%
Race  Death Certificate  White  55  90%  93%
      Black  6  10%  7%
Hispanic  Death Certificate  Hispanic/Latino  0  0%  0%
Education  Death Certificate  <High School  18  31%  22%
      HS graduate  39  67%  74%
      College graduate  0  0%  3%
      Post‐graduate  1  2%  1%
Marital Status  Death Certificate  Single  21  34%  39%
      Married  24  39%  34%
      Divorced  13  21%  23%
      Separated  2  3%  1%
      Widowed  1  2%  2%
Military  Death Certificate 
Ever in US Armed 









Report     33  54%  67%
Verifiable Valid 











Jan‐Sep 9  2010  2009  2008  2007 
Total Cases     97 127 120  138 127
DEMOGRAPHICS                   
Characteristic                   
    Category  Percent  Percent  Percent  Percent  Percent 
Age  <15 years  0% 0% 1%  0% 0%
   15‐24 years  6% 14% 10%  9% 8%
   25‐34 years  18% 22% 18%  21% 17%
   35‐44 years  26% 28% 23%  22% 25%
   45‐54 years  33% 18% 27%  29% 33%
   55‐64 years  10% 16% 7%  8% 11%
   65‐74 years  1% 2% 0%  1% 1%
   75+ years  0% 0% 1%  1% 0%
Gender  Male  61% 57% 57%  61% 63%
   Female  39% 43% 43%  39% 37%
Race  White  88% 90% 84%  86% 80%
   Black  12% 10% 16%  14% 20%
                    
TOXICOLOGY REPORT     2011  2011  2010       
Characteristic  Category  Frequency Percent  Percent       
                    
Alcohol  Alcohol  23 24% 23%       
Illicit Drugs  Marijuana  39 40% 30%       
   Cocaine  39 40% 30%       
   Heroin  32 33% 31%       
Prescription Opioids  Any  61 63% 74%       
   Oxycodone  16 16% 23%       
   Hydrocodone  16 16% 24%       
   Methadone  36 37% 32%       
Benzodiazepines  Any  59 61% 70%       
Frequent Combinations                   
Any Prescription Opioid + Any 
Benzodiazepine     45 46% 57%       
Any Prescription Opioid + Any 
Anti‐Depressant     21 22% 29%       
Heroin Alone     5 5% 7%       
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Rx Drug Abuse Educational Video Series 
 
Prescription Drugs: Questions and Answers — Education for Health Care 
Professionals and the Community 
The nine videos highlighted below, available on YouTube, comprise an educational 
series on prescription drug disorders produced by the Center for Interventions, 
Treatment & Addictions Research (CITAR) at the Wright State University Boonshoft 
School of Medicine. The series was produced to meet an educational objective under a 
contract from Public Health — Dayton and Montgomery County (PHDMC). This project 
was funded, in part, by the Preventive Health and Health Services Block Grant from the 
Centers for Disease Control and Prevention (CDC) and administered by the Ohio 
Department of Health (ODH). The contents of the series are solely the responsibility of 
the presenters and do not necessarily represent the official views of the CDC, ODH, 
PHDMC or Wright State University. 
The series was created and developed by Russel Falck, M.A., associate professor of 
community health and project PI, with Robert Carlson, Ph.D., professor of community 
health, project co‐PI and CITAR director; Raminta Daniulaityte, Ph.D., research assistant 
professor of community health and project co‐investigator; and Tim Lane, M.Ed., the 
project's injury prevention coordinator. Videotaping and editing was provided by Wright 
State's Computing and Telecommunications Services.  
 Pain Management Contracts — featuring Rick Buenaventura, M.D., Anesthesiologist & 
Interventional Pain Management Physician, Pain Relief of Dayton 
 Alternatives to Opioids for Pain Management — featuring Rick Buenaventura, M.D., 
Anesthesiologist & Interventional Pain Management Physician, Pain Relief of Dayton 
 Prescription Drugs and Their Effects (Opioids and Benzodiazepines) — featuring Douglas 
Teller, M.D., Internal Medicine & Addiction Medicine Specialist, Kettering Health Network  
 Prescribing Multiple Drugs: Prescriber Perspectives — featuring Douglas Teller, M.D., Internal 
Medicine & Addiction Medicine Specialist, Kettering Health Network 
 Substance Use Disorders — featuring Brenda Roman, M.D., Professor of Psychiatry, Wright 
State University Boonshoft School of Medicine  
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 Treating Substance Use Disorders — featuring Brenda Roman, M.D., Professor of Psychiatry, 
Wright State University Boonshoft School of Medicine 
 Talking with Someone About Prescription Drug Abuse — featuring Monica Sutter, R.N., 
Chemical Dependency Resource Nurse, Good Samaritan Hospital, Dayton 
 Multiple Drug Prescriptions: Patient Perspectives — featuring Douglas Teller, M.D., Internal 
Medicine & Addiction Medicine Specialist, Kettering Health Network 
 Drug Overdose in Montgomery County: The Scope of the Problem —featuring Tim Lane, 
M.Ed., Injury Prevention Coordinator, Wright State University Boonshoft School of Medicine, 
Center for Interventions, Treatment & Addictions Research 
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Final Recommendations 
 
The Montgomery County Unintentional Poisoning Death Coalition makes the following 
recommendations: 
 
1. Continue to focus on Unintentional Prescription Drug Overdoses by incorporating 
the membership and objectives of the Drug Poisoning Coalition into the 
Montgomery County Community Opiate Task Force, overseen by the Montgomery 
County ADAMHS Board, when it is formed. Consider building on Coalition objectives 
by forming a sub‐group of the Task Force that focuses on preventing prescription 
drug overdose deaths. 
 
2. Continue the Poisoning Death Review process. The continued cooperation of the 
Montgomery County Coroner’s Office would be an essential element of the process, 
and additional resources may be needed to allow the Coroner’s Office to provide the 
data that forms the basis for all PDR activities. 
 
3. Consider implementing a public health‐oriented, social marketing campaign with a 
hierarchical risk reduction message targeting people at high risk for 
unintentionaldrug overdose. This effort could be informed in part by Montgomery 
County Residents Hospital Emergency Department Visits for Accidental Overdose on 
Selected Drugs, 2007‐2010. 
 
4. The Center for Interventions, Treatment, and Addictions Research should continue 
to support Information, Training, and Educational Opportunities, by: 
 ‐maintaining the Coalition web site, including access to the series of nine 
educational videos; 
‐ participating in the scheduled February 2012 training event for clinicians at the 
Miami Valley Hospital; and 
‐ should resources become available, conducting an evaluation of a Naloxone 
Distribution and Education Pilot program, if such a program is conducted in 
Montgomery County. 
